These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 306745)

  • 1. Pi-Z phenotypes in a pulmonary clinic. Their prevalence and physiologic state.
    Gerblich AA; Kleinerman J; Rynbrandt DJ; Chester EH; Ihrig J
    Am J Clin Pathol; 1978 May; 69(5):509-13. PubMed ID: 306745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha 1-antitrypsin Pi-types in 965 COPD patients.
    Lieberman J; Winter B; Sastre A
    Chest; 1986 Mar; 89(3):370-3. PubMed ID: 3485034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Rare
    Ortega VE; Li X; O'Neal WK; Lackey L; Ampleford E; Hawkins GA; Grayeski PJ; Laederach A; Barjaktarevic I; Barr RG; Cooper C; Couper D; Han MK; Kanner RE; Kleerup EC; Martinez FJ; Paine R; Peters SP; Pirozzi C; Rennard SI; Woodruff PG; Hoffman EA; Meyers DA; Bleecker ER;
    Am J Respir Crit Care Med; 2020 Mar; 201(5):540-554. PubMed ID: 31661293
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.
    McDonagh DJ; Nathan SP; Knudson RJ; Lebowitz MD
    J Clin Invest; 1979 Feb; 63(2):299-309. PubMed ID: 311786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
    Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
    Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interrelationships between neutrophil elastase, serum alpha, -antitrypsin, lung function and chest radiography in patients with chronic airflow obstruction.
    Abboud RT; Rushton JM; Grzybowski S
    Am Rev Respir Dis; 1979 Jul; 120(1):31-40. PubMed ID: 313728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).
    Bartmann K; Fooke-Achterrath M; Koch G; Nagy I; Schütz I; Weis E; Zierski M
    Eur J Respir Dis; 1985 Apr; 66(4):284-96. PubMed ID: 3874784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease inhibitor phenotype BsaskatoonM is not associated with emphysema - a 20-year follow-up study.
    Jokic R; Fisher KL; Cockcroft DW
    Can Respir J; 1999; 6(5):407-11. PubMed ID: 10572206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collaborative study to assess risk of lung disease in Pi MZ phenotype subjects.
    Bruce RM; Cohen BH; Diamond EL; Fallat RJ; Knudson RJ; Lebowitz MD; Mittman C; Patterson CD; Tockman MS
    Am Rev Respir Dis; 1984 Sep; 130(3):386-90. PubMed ID: 6332562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.
    Silverman EK; Province MA; Campbell EJ; Pierce JA; Rao DC
    Genet Epidemiol; 1992; 9(5):317-31. PubMed ID: 1427021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 1-antitrypsin deficiency: the radiological features of pulmonary emphysema in subjects of Pi type Z and Pi type SZ: a survey by the British Thoracic Association.
    Gishen P; Saunders AJ; Tobin MJ; Hutchison DC
    Clin Radiol; 1982 Jul; 33(4):371-7. PubMed ID: 6979454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of alpha-antitrypsin heterozygotes (Pi MZ) in patients with obstructive pulmonary disease.
    Shigeoka JW; Hall WJ; Hyde RW; Schwartz RH; Mudholkar GS; Speers DM; Lin CC
    Am Rev Respir Dis; 1976 Dec; 114(6):1077-84. PubMed ID: 1087539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.
    Sørheim IC; Bakke P; Gulsvik A; Pillai SG; Johannessen A; Gaarder PI; Campbell EJ; Agustí A; Calverley PM; Donner CF; Make BJ; Rennard SI; Vestbo J; Wouters EF; Paré PD; Levy RD; Coxson HO; Lomas DA; Hersh CP; Silverman EK
    Chest; 2010 Nov; 138(5):1125-32. PubMed ID: 20595457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes.
    Silverman EK; Province MA; Rao DC; Pierce JA; Campbell EJ
    Am Rev Respir Dis; 1990 Nov; 142(5):1015-21. PubMed ID: 2240821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary function associated with the Mmalton deficient variant of alpha 1-antitrypsin.
    Sproule BJ; Cox DW; Hsu K; Salkie ML; Herbert FA
    Am Rev Respir Dis; 1983 Feb; 127(2):237-40. PubMed ID: 6600898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor profile of black Americans with and without chronic cardiopulmonary disease.
    Young RC; Headings VE; Henderson AL; Bose S; Hackney RL
    J Natl Med Assoc; 1978 Nov; 70(11):849-56. PubMed ID: 309951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease in Yugoslavia.
    Kozarevic D; Laban M; Budimir M; Vojvodic N; Roberts A; Gordon T; McGee DL
    Am Rev Respir Dis; 1978 Jun; 117(6):1039-43. PubMed ID: 307352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin phenotypes and obstructive lung disease in the city of Oslo.
    Gulsvik A; Fagerhol MK
    Scand J Respir Dis; 1979 Oct; 60(5):267-74. PubMed ID: 316573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.
    Cox DW; Hoeppner VH; Levison H
    Am Rev Respir Dis; 1976 May; 113(5):601-6. PubMed ID: 1083700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung function studies in asymptomatic individuals with moderately (Pi SZ) and severely (Pi Z) reduced levels of alpha1-antitrypsin.
    Larsson C; Dirksen H; Sundström G; Eriksson S
    Scand J Respir Dis; 1976; 57(6):267-80. PubMed ID: 1087749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.